Myasthenia gravis (MG) is a chronic neuromuscular disorder characterized by fluctuating skeletal muscle weakness and fatigue. This rare autoimmune condition can present a diagnostic challenge for the advanced practice nurse (APN). Because of its low incidence in clinical practice and frequently unrecognized symptoms, a delay of 1 to 2 years prior to diagnosis is not uncommon. Recognition of the clinical features is a key component of prompt diagnosis. To avoid delay in treatment, APNs should be aware of variations in MG symptoms and the tools used to confirm a suspected diagnosis. Because patients benefit from the care of neuromuscular specialists, APNs are not expected to be experts within MG treatment. But knowledge of general treatment p...
Acquired myasthenia gravis is a relatively uncommon disorder, with prevalence rates that have increa...
We performed a community-based survey of 165 Australian patients with a physician-confirmed diagnosi...
Aim: The aim of this study was to evaluate the demographic characteristics, clinical presentation, a...
Myasthenia gravis (MG) is a chronic neuromuscular disorder characterized by fluctuating skeletal mus...
Myasthenia gravis (MG) is a rare autoimmune disorder characterised by fluctuating and variable combi...
Myasthenia gravis (MG) is an autoimmune disease caused by antibodies against the acetylcholine recep...
J O U R N A L Neurons: A Peer-reviewed International Neuroscience Journal ISSN: 2348-3237 | Pub...
Myasthenia gravis (MG) is a chronic neurologic disease and the most common disease of neuromuscular ...
Myasthenia gravis (MG) is a disorder of the neuromuscular junction (NMJ) that causes fatigue and flu...
Myasthenia gravis (MG) is an autoantibody-mediated disease that compromises the acetylcholine recept...
Earlier diagnosis and the availability of effective treatments have reduced the burden of high morta...
Myasthenia gravis (MG) is a disorder of the neuromuscular junction (NMJ) that causes fatigue and flu...
Myasthenia gravis (MG) is a neuromuscular autoimmune disease that affects the skeletal muscle throug...
Myasthenia Gravis (MG) is an autoimmune disorder of neuromuscular transmission in which acetylcholin...
Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular transmission leading to gen...
Acquired myasthenia gravis is a relatively uncommon disorder, with prevalence rates that have increa...
We performed a community-based survey of 165 Australian patients with a physician-confirmed diagnosi...
Aim: The aim of this study was to evaluate the demographic characteristics, clinical presentation, a...
Myasthenia gravis (MG) is a chronic neuromuscular disorder characterized by fluctuating skeletal mus...
Myasthenia gravis (MG) is a rare autoimmune disorder characterised by fluctuating and variable combi...
Myasthenia gravis (MG) is an autoimmune disease caused by antibodies against the acetylcholine recep...
J O U R N A L Neurons: A Peer-reviewed International Neuroscience Journal ISSN: 2348-3237 | Pub...
Myasthenia gravis (MG) is a chronic neurologic disease and the most common disease of neuromuscular ...
Myasthenia gravis (MG) is a disorder of the neuromuscular junction (NMJ) that causes fatigue and flu...
Myasthenia gravis (MG) is an autoantibody-mediated disease that compromises the acetylcholine recept...
Earlier diagnosis and the availability of effective treatments have reduced the burden of high morta...
Myasthenia gravis (MG) is a disorder of the neuromuscular junction (NMJ) that causes fatigue and flu...
Myasthenia gravis (MG) is a neuromuscular autoimmune disease that affects the skeletal muscle throug...
Myasthenia Gravis (MG) is an autoimmune disorder of neuromuscular transmission in which acetylcholin...
Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular transmission leading to gen...
Acquired myasthenia gravis is a relatively uncommon disorder, with prevalence rates that have increa...
We performed a community-based survey of 165 Australian patients with a physician-confirmed diagnosi...
Aim: The aim of this study was to evaluate the demographic characteristics, clinical presentation, a...